The GI symptoms of abdominal pain, gas, diarrhea, and constipation are associated with a greater risk for worsened ASD symptoms including withdrawal, irritability, and hyperactivity [38]
(eClinicalMedicine, 2024) - found that 52 weeks of once-weekly semaglutide at 1.0 mg reduced hip bone mineral density by 2.6% and lumbar spine BMD by 2.1% compared to placebo in 64 adults with elevated fracture risk
[DOI] [PubMed] [Google Scholar] 37.Lincoff A.M., Brown-Frandsen K., Colhoun H.M., Deanfield J., Emerson S.S., Esbjerg S., Hardt-Lindberg S., Hovingh G.K., Kahn S.E., Kushner R.F., et al
A biosimilar applicant must provide its application to the reference product sponsor within 20 days of FDA acceptance
By managing the effects of free radical damage, it helps protect skin cells from premature ageing and environmental damage
Although the reasons for the relatively low utilization of oral semaglutide are unknown, it is possible that the dosing requirements of oral semaglutide are less familiar to physicians and people with T2D than the more established DPP-4is
